I’m at the ISSCR meeting in Barcelona, taking notes on talks and conversations. Writing that up is on the to-do list for tonight. Meanwhile, here’s a quick plug for NPG. The 2 July issue of Nature is packed with stem cell content. The two stacks of free copies disappeared from the venue’s literature tables before the first set of talks finished. For those of you who didn’t arrive early enough, here’s what was in that issue, along with a few stories that appeared online since then.
But results are only preliminary, researchers caution.
Biomedical agency announces new funding policy for cell lines.
Departure raises questions over leadership at flagship centre.
Letter to the editor
US researchers rely on very few lines; the NIH should consider what diversity is desired
Review by Shinya Yamanaka
Elite and stochastic models for induced pluripotent stem cell generation Can any cell be reprogrammed to pluripotency?
See related Nature Reports story:Gene therapy combined with reprogramming makes disease-free cells
See related Nature Reports story: Regenerating limb tissue may not dedifferentiate
Nature Reports provides a peek into peer review for this paper
A Nature news story on the cells being studied in clinical trials for heart disease
See a related Nature Reports story: A tale of two LIFs